jte 522 has been researched along with Carcinoma, Epidermoid in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kawakami, K; Mizuno, H; Nishimura, G; Tsukuda, M; Yanoma, S | 1 |
1 other study(ies) available for jte 522 and Carcinoma, Epidermoid
Article | Year |
---|---|
A selective cyclooxygenase-2 inhibitor suppresses tumor growth in nude mouse xenografted with human head and neck squamous carcinoma cells.
Topics: Animals; Benzenesulfonates; Carcinoma, Squamous Cell; Cell Cycle; Cell Division; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Cytotoxicity, Immunologic; Female; G1 Phase; Head and Neck Neoplasms; Humans; Isoenzymes; KB Cells; Killer Cells, Lymphokine-Activated; Killer Cells, Natural; Membrane Proteins; Mice; Mice, Nude; Oxazoles; Platelet-Derived Growth Factor; Prostaglandin-Endoperoxide Synthases; Telomerase; Transplantation, Heterologous | 1999 |